Related references
Note: Only part of the references are listed.Risk Factors for Unresectable Recurrence After Up-Front Surgery for Colorectal Liver Metastasis
Daisuke Hokuto et al.
WORLD JOURNAL OF SURGERY (2018)
The Tumor Burden Score: A New Metro-ticket Prognostic Tool For Colorectal Liver Metastases Based on Tumor Size and Number of Tumors
Kazunari Sasaki et al.
ANNALS OF SURGERY (2018)
Genetic And Morphological Evaluation (GAME) score for patients with colorectal liver metastases
G. A. Margonis et al.
BRITISH JOURNAL OF SURGERY (2018)
Phase II trial of neoadjuvant chemotherapy with S-1 and oxaliplatin plus bevacizumab for colorectal liver metastasis (N-SOG 05 trial)
Toshiki Mukai et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2017)
Systematic review of systemic adjuvant, neoadjuvant and perioperative chemotherapy for resectable colorectal-liver metastases
Emily Khoo et al.
HPB (2016)
Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial
Ninos Ayez et al.
BMC CANCER (2015)
Phase II multicenter study of adjuvant S-1 for colorectal liver metastasis: survival analysis of N-SOG 01 trial
Takehiro Kato et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
The use of neo-adjuvant chemotherapy in patients with resectable colorectal liver metastases: Clinical risk score as possible discriminator
N. Ayez et al.
EJSO (2015)
Neoadjuvant chemotherapy for resectable colorectal liver metastases: What is the evidence? Results of a systematic review of comparative studies
Giuseppe Nigri et al.
SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND (2015)
Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial
John Primrose et al.
LANCET ONCOLOGY (2014)
Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial
Bernard Nordlinger et al.
LANCET ONCOLOGY (2013)
A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery
Toru Beppu et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2012)
Survival after Hepatic Resection for Metastatic Colorectal Cancer: Trends in Outcomes for 1,600 Patients during Two Decades at a Single Institution
Michael G. House et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2010)
Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy
Scott Kopetz et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Prognostic factors and evaluation of a clinical score for predicting survival after resection of colorectal liver metastases
Ralf Konopke et al.
LIVER INTERNATIONAL (2009)
Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer - A multifactorial model of 929 patients
Myrddin Rees et al.
ANNALS OF SURGERY (2008)
Adjuvant Chemotherapy After Potentially Curative Resection of Metastases From Colorectal Cancer: A Pooled Analysis of Two Randomized Trials
Emmanuel Mitry et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
Bernard Nordlinger et al.
LANCET (2008)
Hepatic resection for colorectal metastases - Value for risk scoring systems?
Shaheen Zakaria et al.
ANNALS OF SURGERY (2007)
Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial
Guillaume Portier et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Proposal of criteria to select candidates with colorectal liver metastases for hepatic resection: Comparison of our scoring system to the positive number of risk factors
Ikuo Nagashima et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Extending the frontiers of surgical therapy for hepatic colorectal metastases: Is there a limit?
VP Khatri et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver
K Tanaka et al.
BRITISH JOURNAL OF SURGERY (2003)
Trends in long-term survival following liver resection for hepatic colorectal metastases
MA Choti et al.
ANNALS OF SURGERY (2002)
Share Paper
